n.假粘液瘤

Pseudomyxoma peritonei is a rare condition characterized by the accumulation of mucinous material in the abdominal cavity.
胸腹膜假黏液瘤是一种罕见的病症，特征是腹腔内积聚黏液性物质。
The diagnosis of pseudomyxoma peritonei often relies on histopathological examination of the cyst fluid or tissue samples.
对胸腹膜假黏液瘤的确诊通常需要依赖于囊液或组织样本的病理学检查。
Treatment options for pseudomyxoma peritonei include surgery, chemotherapy, and targeted therapy, depending on the stage and severity of the cancer.
对胸腹膜假黏液瘤的治疗选择包括手术、化疗和靶向疗法，具体取决于癌症的阶段和严重程度。
In some cases, pseudomyxoma peritonei can be a complication of ovarian or gastrointestinal cancers, necessitating a multidisciplinary approach to management.
在某些情况下，胸腹膜假黏液瘤可能是卵巢或消化道癌症的并发症，需要多学科管理。
A patient with recurrent pseudomyxoma peritonei may require repeat surgeries and close monitoring by oncologists to manage the disease progression.
有复发性胸腹膜假黏液瘤的患者可能需要多次手术，并且需要肿瘤学家密切监测疾病进展。
Symptoms of pseudomyxoma peritonei can vary, but common complaints include abdominal pain, bloating, and the sensation of a large,移动 mass.
胸腹膜假黏液瘤的症状各异，常见的包括腹部疼痛、腹胀以及感觉到一个大的可移动肿块。
Early detection of pseudomyxoma peritonei is crucial for improving prognosis, as it allows for more effective treatment options.
提前发现胸腹膜假黏液瘤对于改善预后至关重要，因为它可以为更有效的治疗提供机会。
Postoperative follow-up for pseudomyxoma peritonei patients often involves regular imaging scans to monitor for recurrence or complications.
对胸腹膜假黏液瘤患者的术后随访通常包括定期的影像扫描，以监测复发或并发症。
Some researchers are exploring immunotherapy as a potential new treatment for advanced stages of pseudomyxoma peritonei, though more clinical trials are needed.
一些研究者正在探索免疫疗法作为治疗晚期胸腹膜假黏液瘤的潜在新方法，但还需要更多的临床试验来证实。
Supportive care, including pain management and nutritional counseling, is also an essential aspect of the overall management of pseudomyxoma peritonei patients.
对胸腹膜假黏液瘤患者的综合管理还包括支持性护理，如疼痛管理和营养咨询。